|
Post by smwill77 on Jan 11, 2016 16:22:41 GMT -5
I got a firm confirmation that Mnkd wouldn't pull out of the Conf, Ray (CMO) will present TS Road Map. Matt will present Afrezza game plan, strategic options including future partners, marketing strategy, financial situation, plan to extend runway. There are 2 presenters from Mnkd, suprised !!Also heard TS partner for Pain mgmt, Migraine....... Individual investors can post questions and get immediate answers. It gonna be an open forum, no holds barred, only time is the limiting factor. Please come prepare with written, electronic Qs so that you can cut and paste fast. Let's seize this opportunity to really grill mgmt. Don't complain if you are not prepared. Give it up, Lakers. You're just guessing and posting for the attention.
|
|
|
Post by bradleysbest on Jan 11, 2016 16:23:10 GMT -5
Not doubting you but hope this is true!
|
|
|
Post by dreamboatcruise on Jan 11, 2016 16:25:20 GMT -5
I got a firm confirmation that Mnkd wouldn't pull out of the Conf, Ray (CMO) will present TS Road Map. Matt will present Afrezza game plan, strategic options including future partners, marketing strategy, financial situation, business model, plan to extend runway. There are 2 presenters from Mnkd, suprised !!Also heard TS partner for Pain mgmt, Migraine....... Individual investors can post questions and get immediate answers. It gonna be an open forum, no holds barred, only time is the limiting factor. Please come prepare with written, electronic Qs so that you can cut and paste fast. Let's seize this opportunity to really grill mgmt. Don't complain if you are not prepared. I guess Matt is as yet unaware that Medtronic has already bought MNKD... according to some posters on other threads. That will be awkward for him if he learns of that during the presentation.
|
|
|
Post by peppy on Jan 11, 2016 16:25:59 GMT -5
Here is a question, Who will get the clamp study data and the pediatric study data and when? Will Mannkind get this data as the study is sanofi's study? When?
|
|
|
Post by me on Jan 11, 2016 16:27:03 GMT -5
Here is a question, Who will get the clamp study data and the pediatric study data and when? 1. MNKD 2. No later than the end of the termination of the final wind down period.
|
|
|
Post by dreamboatcruise on Jan 11, 2016 16:28:22 GMT -5
Here is a question, Who will get the clamp study data and the pediatric study data and when? I'm sure that turning over all the data and whatever analysis has been done already, if any, would be considered an obligation that SNY must fulfill.
|
|
|
Post by alethea on Jan 11, 2016 16:29:05 GMT -5
I got a firm confirmation that Mnkd wouldn't pull out of the Conf, Ray (CMO) will present TS Road Map. Matt will present Afrezza game plan, strategic options including future partners, marketing strategy, financial situation, plan to extend runway. There are 2 presenters from Mnkd, suprised !!Also heard TS partner for Pain mgmt, Migraine....... Individual investors can post questions and get immediate answers. It gonna be an open forum, no holds barred, only time is the limiting factor. Please come prepare with written, electronic Qs so that you can cut and paste fast. Let's seize this opportunity to really grill mgmt. Don't complain if you are not prepared. Give it up, Lakers. You're just guessing and posting for the attention. Weren't you saying with near certainty in December that Sanofi partnership was very strong? You've said a lot of things and implied you have inside source(s). How about it? What did you say not long ago about how sure you were that the partnership was going very well?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 11, 2016 16:30:01 GMT -5
The current situation as dire as is I really do not understand why they would not release specifics on Technosphere.
I mean naming a partner, upfront money not the constant BS.
|
|
|
Post by compound26 on Jan 11, 2016 16:31:11 GMT -5
I got a firm confirmation that Mnkd wouldn't pull out of the Conf, Ray (CMO) will present TS Road Map. Matt will present Afrezza game plan, strategic options including future partners, marketing strategy, financial situation, business model, plan to extend runway. There are 2 presenters from Mnkd, suprised !!Also heard TS partner for Pain mgmt, Migraine....... Individual investors can post questions and get immediate answers. It gonna be an open forum, no holds barred, only time is the limiting factor. Please come prepare with written, electronic Qs so that you can cut and paste fast. Let's seize this opportunity to really grill mgmt. Don't complain if you are not prepared. lakers , thanks for the update! I agree that Mannkind better participate in the conference. If nothing else (i.e., no news on Afrezza partnership or TS license agreement), they still need to outline their plans going forward so as to give confidence to the prescribing doctors, patients and insurance companies that Afrezza will not be dropped because of Sanofi's termination of the license agreement. Even though Matt has declared that patient access will not be impaired during transition from Sanofi to Mannkind, Mannkind still needs to reaffirm this and affirmatively declare that Afrezza will stay much longer than that (the transition period). Mannkind needs to send such message to the public as affirmatively as possible and as early as possible. The JPM conference is the best venue to do it at this moment. At this moment, Mannkind can not hide away, without affirmative message from Mannkind that Afrezza will stay, the prescribing doctors will hesitate to write new prescriptions and new patients will hesitate to try out Afrezza.
|
|
|
Post by inittowinit on Jan 11, 2016 16:32:52 GMT -5
Lakers,
I've always valued your input here, enough to give you the benefit of doubt. This board NEEDS some positive news...
|
|
|
Post by dreamboatcruise on Jan 11, 2016 16:34:17 GMT -5
alethea... I for one will freely admit that I had been stating that I saw little chance of SNY dropping Afrezza. I was shockingly, horribly wrong about that, and as such I would suggest no one, especially me, ever pay any attention to my opinions again.
|
|
|
Post by smwill77 on Jan 11, 2016 16:35:43 GMT -5
Give it up, Lakers. You're just guessing and posting for the attention. Weren't you saying with near certainty in December that Sanofi partnership was very strong? You've said a lot of things and implied you have inside source(s). How about it? What did you say not long ago about how sure you were that the partnership was going very well? Exactly. He must have cut his teeth over on yahoo before he got lucky with one or two good guesses over here. Bad news is he guessed very wrong on the big ones and now doesn't know when to quit (and unfortunately continues to mislead people.)
|
|
|
Post by lakers on Jan 11, 2016 16:38:51 GMT -5
Give it up, Lakers. You're just guessing and posting for the attention. Weren't you saying with near certainty in December that Sanofi partnership was very strong? You've said a lot of things and implied you have inside source(s). How about it? What did you say not long ago about how sure you were that the partnership was going very well? Mgmt didn't have any inkling of Sanofi bailing out either. Everyone was equally blindsided when receiving Sanofi notice on the fateful Jan 4th, 2016. It's water under the bridge. You need to look forward.
|
|
|
Post by jefferson on Jan 11, 2016 16:39:02 GMT -5
Totally disagree. Lakers has been as asset to this board. No one here knows shit. Just look at your trade accounts.
|
|
|
Post by alethea on Jan 11, 2016 16:41:04 GMT -5
alethea ... I for one will freely admit that I had been stating that I saw little chance of SNY dropping Afrezza. I was shockingly, horribly wrong about that, and as such I would suggest no one, especially me, ever pay any attention to my opinions again. Dreamboat, my post was directed squarely at Lakers. He posts endlessly with an authoritative tone yet refuses to answer a simple question. Do you recall him talking up the joint venture as if he had almost inside information or am I just imagining it?
|
|